Danaher’s $9.9B Masimo Deal Marks One of 2026’s Largest Medtech Buyouts
Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped 30.27% ...
Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped 30.27% ...
Copyright © 2022-2024
All Rights Reserved
See articles for original source and related links to external sites.
Copyright © 2022-2024
All Rights Reserved
See articles for original source and related links to external sites.